Should You Buy Neil Woodford’s China-Proof Shares Imperial Tobacco Group PLC, AstraZeneca plc And BT Group plc?

Neil Woodford’s top holdings Imperial Tobacco Group PLC (LON:IMT), AstraZeneca plc (LON:AZN) and BT Group plc (LON:BT.A) are an antidote to his concerns about China.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Renowned fund manager Neil Woodford has been concerned for some time about the Chinese economy, and what it means for the global economy as a whole. He discusses the subject in some detail in a blog post today.

Woodford suggests that recent growth figures coming out of China have lacked credibility when compared with other real economic data, noting:

“Even the Chinese Premier, Li Keqiang, allegedly mistrusts the country’s official economic statistics, preferring to track growth by looking at real data. The Li Keqiang Index, as it has become known, tracks growth in outstanding bank loans, electricity production and rail freight volumes, and currently shows a reading of just 2.5% year-on-year. It last visited that level in November 2008, just after Lehman collapsed”.

Woodford suggests that the number of reasons to be cautious about China is increasing. He particularly highlights what will be an inevitably long and bumpy transition from heavy infrastructure investment to a more Western consumption-based economy. Furthermore, he reckons the State is struggling to adopt the required political approach for such a transition, as demonstrated by recent interventions in the stock and currency markets.

The level of private sector debt in the Chinese economy is another big concern Woodford highlights. He says the level is “alarming” and suggests that the Chinese economy will have to go through “a period of prolonged debt moderation”. He also notes that China has scope to lower interest rates, which could export deflation to the rest of the world, with “signification ramifications for the global economic outlook”.

Woodford-watchers will know he has been concerned about the risks emanating from China for some years, and has built his portfolios in the expectation that there’ll be little help from macroeconomic tailwinds. As such, he has populated his portfolios with companies that are more in control of their own destinies — avoiding, oil companies, miners and banks.

The top holding in Woodford’s equity income fund, Imperial Tobacco (LSE: IMT), is a prime example of a company more in control of its own destiny. Tobacco consumption is not really dependent on buoyant economies. The industry does face some headwinds, caused by increased health awareness in developed countries, but Woodford reckons the prospects and cash-generative qualities of tobacco companies continue to be under-appreciated by the market. Imperial trades on a forward P/E of 15 and offers a prospective 4.4% dividend yield, which looks attractive for such a “defensive” company.

Woodford’s no. two holding AstraZeneca (LSE: AZN) may be at the other end of the health spectrum to Imperial, but it also has solid defensive qualities. In addition, the big pharma company should benefit from demographic trends of ageing populations. Woodford believes Astra did the right thing in rejecting a £55 a share takeover bid by US giant Pfizer last year. With the shares now trading at under £42 (forward P/E 16, yield 4.2%) you have an idea of how much value Woodford sees in the company.

BT (LSE: BT-A) is another of Woodford’s top five holdings. Increasingly, packages of fixed line, mobile, broadband and pay-TV are becoming more of a staple for consumers than a luxury. BT’s agreed acquisition of mobile group EE will extend the group’s capabilities, and, after some initial concerns, Woodford decided that the acquisition was a good move for BT and its shareholders. If he’s right, BT’s current forward P/E of 13 and yield of 3.5% represent excellent value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »